CurrentEndo
Get Weekly

Topic · page 8 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 281–320 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Cardiovasc Diabetol

    Multi-omics signatures of circulating factors associated with cardiorespiratory fitness adaptations in individuals with prediabetes

    Mechanistic study

  2. Cardiovasc Diabetol

    Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study

    Cohort study

  3. Osteoporos Int

    Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes

    Cohort study

  4. Cardiovasc Diabetol

    Henagliflozin attenuates adverse ventricular remodeling and improves cardiometabolic parameters in patients with type 2 diabetes and hypertension: real-world evidence from a propensity score-matched analysis

    Cohort study

  5. Diabetes Metab

    Association between the glycemic risk index and peripheral atherosclerosis in hospitalized patients with type 2 diabetes: a cross-sectional study

    Cross-sectional study

  6. Diabetes Res Clin Pract

    Associations between prediabetes, type 2 diabetes, and incident arrhythmias: a population-based cohort study and Mendelian randomization analysis

    Cohort study

  7. BMJ Open Diabetes Res Care

    Prevalence, incidence, mortality, and years of life lost to diabetes from 1996 to 2024 in Denmark

    Cohort study

  8. Diabetes Res Clin Pract

    Exercise training for executive function in type 2 diabetes: A systematic review and practice implications

    Meta-analysis

  9. Cardiovasc Diabetol

    Comparative effectiveness of dual antiplatelet therapy after revascularization in diabetes and chronic limb-threatening ischemia: a target trial emulation study

    Cohort study

  10. Diabetes Obes Metab

    Efficacy and Safety of SGLT2 Inhibitors and GLP ‐1 Receptor Agonists on Ventricular Arrhythmias and Cardiovascular Events: A Disease‐Stratified Network Meta‐Analysis

    Meta-analysis

  11. Diabetes Obes Metab

    Baseline Computed Tomography Coronary Angiography and Polygenic Risk Profiles in Adults With Type 2 Diabetes: A Cross‐Sectional Analysis From the VOLTAIRE Study

    Cross-sectional study

  12. Diabetes Obes Metab

    Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP ‐1 Receptor Agonists

    Cohort study

  13. Diabetes Res Clin Pract

    Burden of type 2 diabetes attributable to dietary risks in 34 Asian countries: the Global Burden of Disease Study 2023

    Research article

  14. JAMA

    Insulin Costs and Use by Medicare Beneficiaries After the Inflation Reduction Act Out-of-Pocket Cap

    Research article

  15. Endocr Pract

    Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial

    Randomized controlled trial

  16. Cardiovasc Diabetol

    Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies

    Meta-analysis

  17. Diabetes Obes Metab

    Efficacy and Safety of the Dual Glucagon‐Like Peptide‐1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysis

  18. Cardiovasc Diabetol

    Synergistic SGLT2 and GLP-1R targeting alleviates systemic inflammation-induced and M1 monocyte-driven endothelial dysfunction in coronary artery disease

    Mechanistic study

  19. Diabetes Res Clin Pract

    Effects of garlic supplementation on glycemic indices in adults: a GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials

    Meta-analysis

  20. Diabetologia

    Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity

    Cross-sectional study

  21. Diabetes Res Clin Pract

    Consensus Recommendations on Lipohypertrophy: Insights From an International Panel of Experts

    Guideline or statement

  22. Diabetes Obes Metab

    Trends in Prevalence of Diabetes, Pre‐Diabetes, and Cardiometabolic Risk Factor Control Among U.S. Adults, 2013–2023

    Cross-sectional study

  23. Diabetes Obes Metab

    First‐Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial

    Randomized controlled trial

  24. Diabetes Obes Metab

    A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline

    Research article

  25. J Clin Endocrinol Metab

    Genetic and clinical factors associated with metformin plasma concentrations following an acute metformin challenge

    Cohort study

  26. Diabetologia

    Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions

    Cohort study

  27. Diabetologia

    GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study

    Randomized controlled trial

  28. Diabet Med

    Disentangling the effect of brain insulin resistance on brain health ( BIR ‐ BrainHealth ): Rationale and study protocol

    Trial design

  29. Diabetes Res Clin Pract

    Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes

    Cohort study

  30. J Diabetes Sci Technol

    Quality of In-Use Insulin Under Real-World Storage Conditions in Mwanza, Tanzania

    Cross-sectional study

  31. JAMA Netw Open

    Antipsychotic Exposure and Pharmacologically Treated Type 2 Diabetes in Dutch Youths

    Cohort study

  32. Diabetes Obes Metab

    Efficacy and Safety of Intensifying Once‐Weekly Insulin Icodec Treatment With Once‐Weekly Semaglutide in Adults With Type 2 Diabetes: A Single‐Arm, Open‐Label, Treat‐to‐Target, Phase 3b Trial ( ONWARDS 8)

    Research article

  33. Diabetes Obes Metab

    Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once‐Weekly Basal Insulin Icodec

    Research article

  34. JAMA Netw Open

    Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes

    Cohort study

  35. Diabetes Obes Metab

    Impact of iGlarLixi on Glycaemic Control Depth and Variability in Asian Pacific People With Type 2 Diabetes: A Post Hoc Analysis of LixiLan ‐O‐ AP and LixiLan ‐L‐ CN

    Secondary analysis

  36. Diabetes Obes Metab

    Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE ‐O Trial

    Secondary analysis

  37. Diabetologia

    Remodelling of body composition surrounding the diagnosis of type 2 diabetes in three longitudinal cohorts

    Cohort study

  38. Diabetologia

    History of infertility, risk of type 2 diabetes and HbA1c levels in the Nurses’ Health Study II

    Cohort study

  39. Endocr Pract

    Tirzepatide Versus Conventional Glucagon-Like Peptide-1 Receptor Agonists for Treatment Simplification in Type 2 Diabetes Mellitus: A Real-World Study

    Cohort study

  40. BMJ Open Diabetes Res Care

    Alpha cell dysfunction in type 2 diabetes: associations with insulin resistance and reduced insulin secretion

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 281–320 of 4,758, newest first